Infusion Magazine |
REGULATORY/LEGISLATIVE ISSUES
Alborghetti M. Medical waste: No "throw-away" issue. 1999;5(12):20-5.
Antone TM, Sylvia LM. Operation Restore Trust and Wedge unit investigations: A survival guide. 1997;4(3):14-22.
Appel HM. Moving toward PPS: The shift is upon us. 1998;5(2):35-37.
Baker Kenneth R. Sterile compounding oversight: Legal challenges, practice considerations.200713(2);20-3.
Barrell JM. Infusion providers wake up to the future. 1998;4(10):37-40.
Barrell JM. Corporate compliance starts with commitment. 1998;4(10):51-54.
Barrell JM. Grassroots advocacy: Even in Washington, it's the people that matter. 2000;6(4):11-5.
Barrell JM. Legislative and regulatory review. 2002;8(3):22-9.
Borfitz D. Home health care agency quagmire offers lessons for home infusion. 1999;5(10):35-37.
Carder EB. Enforcement activity in home I.V. therapy. 1995;1(5):28-32.
Counce J. HIPAA security rule imminent, providers best prepare. 2004;10(4):28-32.
Counce J. Medicaid simplified: How standardization could streamline home infusion claims to Medicaid. 2004;10(5):28-31.
Counce JB. Home IGIV under Medicare: Patients still waiting for meaningful coverage. 2005:11(2):12-20.
Counce JB. Medicare part D: The education begins. 2005. 11(3):18-21.
Counce JB. Average sales price and home infusion: What does the future hold? 2005. 11(3):26-31.
Counce: JB. Providers meet policymakers: NHIA’s first-ever legislative conference brings Medicare Part D concerns to forefront. 11(6):21-5.
Counce J. The NHIA 2nd annual legislative conference: Read all about it! 2006. 12(5):12-17.
Counce J. Bringing it home: Pennsylvania provider hosts facility tours for legislators. 2006.12(5):19-21.
Counce J. The NHIA 3rd annual legislative conference: The push for meaningful Medicare coverage continues.2007:13(5);17-21.
Counce J. Taking it to the streets: What you can—and should--do at home to push for meaningful Medicare coverage of home infusion therapies.2007:13(5);25-7.
Dasher T. Heads up for the balanced budget act of 1997. 1998;4(4):45-46.
Dentino-Olson P. Getting it right the first time: Understanding the structure of Medicare Part B reimbursement for home infusion therapy.2008:14(2);24-7.
Dobson A, Lamphere J, Koenig L, and Babcock J. Impact of proposed AWPs on the provision of home care drug therapies to medicare and medicaid patients. 2001;7(2):22-7.
Flores KA. Compliance: A part of your quality improvement process. 2000;6(6):27-30.
Franklin DM. Regulatory compliance: Self-preservation skills in a perilous environment. 2001;7(5):34-8.
Franklin DM. Compliance defined. 2003;9(2):42-6.
Franklin DM. CMS makes major changes to the Medicare appeals process. 11(4):47-50.
Franklin DM. Medicare Part D: The first year in review.2007:13(1);40-3.
Franklin DM. Revolution!2007:13(4);39-24.
Franklin DM. Post-payment audit strategies.2007:13(5);40-2.
Franklin DF. Pharmacy and Medicare Part B: A brief overview.2007:13(6);41-4.
Franklin DM. Competitive Bidding: A Stratagem of Fools. 2008;14(4):43-6.
Ginsburg PB. Competition in health care: Its evolution over the past decade. 2006.12(6):28-37.
Hedlund CT. Stark II: More on HCFA's proposed regulation. 1998;4(7):51-55.
Hedlund CT. Stark II: How HCFA's proposed regulations affect infusion providers. 1998;4(6):42-45
Hedlund CT. Get ready for Stark II. 1994;1(2):15-18.
Kaplan LK. Captive referrals: The legal implications. 1996;2(10):27.
Kaplan LK. Collective negotiation: An idea whose time has come. 1999;5(11):10-13.
Kaplan LK. Home infusion coding and claiming: Big changes are in the works. 2000;7(1):40-1.
Kaplan LK. HIPAA, HIEC, and home infusion claiming and coding: Questions and answers. 2000;7(1):42-5.
Kaplan LK. How to use the new HCPCS home infusion codes. 2002;8(2):24-8.
Kaplan LK. PBMs: A review of litigation and legislation. 2003;9(6):14-9.
Maranville C. Home infusion therapy under Medicare Par D: One provider’s experience.2007:13(2);35-9.
Masoorli S. Central vascular access devices in home care: Legal issues. 2000;6(10):31-5.
NHIA and NAIT join forces to fight deep enteral formula cuts. 1998;5(3):32-39.
NHIA. Consolidating home infusion therapy coverage under Medicare Part B could save the Medicare program millions of dollars in 2006. 11(6):37-8.
NCPA. APHA, NACDS. Implementing effective change in meeting the demands of community pharmacy practice in the United States: A white paper. 1999;6(2):43-8.
Richardson RJ. NHIA raises concerns on proposed Medicare policies for home parenteral nutrition. 1995;1(11):28-36.
Rodman B and Counce J. Trouble getting home: Study finds Medicare Part D hampers access for home infusion therapy access for dual-eligible patients.2007:13(1);34-7.
Rollins G. Prompt payment laws: A new weapon in the managed care struggle. 2000;6(9):21-4.
Rollins G. The Medicaid AWP challenge: Providers respond. 2000;7(1):36-.9
Rollins G. Spotlight on HIPAA privacy and patient rights. 2003;9(2):14-9.
Salvatore T, Baxter T. Beyond compliance: Building an ethical framework for your organization. 1998;5(2):39-42.
Shenton W. HIPAA: Is it overhyped. 2001;7(3):18-25.
Smith DE. In the Driver's Seat. 2000;6(9):35-8.
Stribling C. Managing risk with corporate compliance programs.200713(2);25-8.
Tallon R. DMERC policy perspectives: Food for thought. 1994;1(1):20-23.
Tallon RW. IDPN: The controversy continues. 1994;1(3):22-26.
Vance S. Communicating with congress. 2001;7(2):28-30.
Warren MW, Andrusko-Furphy KT. OASIS and home infusion: Measurement or mirage? 1999;5(8):38-43.
Weber P. Providers and payers will soon be speaking the same language: Electronic claims under HIPAA. 2003;9(4):16-20.